Modulation of FAS and FASL expression
Details for Australian Patent Application No. 2001268863 (hide)
International Classifications
Event Publications
17 July 2003 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 26 Jun 2003
19 October 2006 Amendment Made
The nature of the amendment is: Add priority details 18479/01 13 Dec 1999 and 60/170325 13 Dec 1999 US 2001276460 BioNumerik Pharmaceuticals, Inc. The nature of the amendment is: Amend the invention title to read Method for preparing disodium 2,2'-dithiobis(ethanesulphonate)
5 July 2007 Application Accepted
Published as AU-B-2001268863
1 November 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2001268864-Water recovery, primarily in the cathode side, of a proton exchange membrane fuel cell
2001268862-Composition for pain mediation and apparatus and method of use thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser